A new era in type 2 diabetes mellitus treatment?
Laws
A
A
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D020909:Acarbose / Q000494:pharmacology; D002219:Carbamates / Q000494:pharmacology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D050112:Imino Pyranoses; D015337:Multicenter Studies as Topic; D000077205:Pioglitazone; D010880:Piperidines / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use; D045162:Thiazolidinediones
D002219:Carbamates; D007004:Hypoglycemic Agents; D050112:Imino Pyranoses; D010880:Piperidines; D013844:Thiazoles; D045162:Thiazolidinediones; C045621:miglitol; D017485:1-Deoxynojirimycin; C072379:repaglinide; C089946:2,4-thiazolidinedione; D005944:Glucosamine; D020909:Acarbose; D000077205:Pioglitazone